October Pharma S.A.E (EGX:OCPH)
Egypt · Delayed Price · Currency is EGP 210.61
-1.47 (-0.69%)
At close: Nov 12, 2026
October Pharma S.A.E Revenue
October Pharma S.A.E had revenue of 374.47M EGP in the quarter ending September 30, 2025, with 14.84% growth. This brings the company's total for the last twelve months to 1.46B, up 22.51% year-over-year. In the year 2024, October Pharma S.A.E had annual revenue of 1.23B with 21.39% growth. That makes October Pharma S.A.E the 31,963rd largest company in the world by revenue and 118th in Egypt.
Revenue (ttm)
1.46B
Revenue Growth
+22.51%
P/S Ratio
3.46
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.05B
Revenue by Geography
- Egypt 1.14B 92.7%
- Export 89.23M 7.3%
Fiscal year ended Dec 31, 2024 See the full October Pharma S.A.E breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.23B | 216.38M | 21.39% |
| Dec 31, 2023 | 1.01B | 284.28M | 39.08% |
| Dec 31, 2022 | 727.37M | 72.33M | 11.04% |
| Dec 31, 2021 | 655.04M | 111.64M | 20.54% |
| Dec 31, 2020 | 543.40M | 20.28M | 3.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.